358 related articles for article (PubMed ID: 10403930)
1. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Hasegawa M; Sato S; Takehara K
Clin Exp Immunol; 1999 Jul; 117(1):159-65. PubMed ID: 10403930
[TBL] [Abstract][Full Text] [Related]
2. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis.
Kaburagi Y; Shimada Y; Nagaoka T; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2001 Jul; 293(7):350-5. PubMed ID: 11550808
[TBL] [Abstract][Full Text] [Related]
3. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment.
Fillion I; Ouellet N; Simard M; Bergeron Y; Sato S; Bergeron MG
J Immunol; 2001 Jun; 166(12):7353-61. PubMed ID: 11390486
[TBL] [Abstract][Full Text] [Related]
4. CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications.
Rau B; Baumgart K; Krüger CM; Schilling M; Beger HG
Intensive Care Med; 2003 Apr; 29(4):622-9. PubMed ID: 12589535
[TBL] [Abstract][Full Text] [Related]
5. Coordinate up-regulation of the beta-chemokine subfamily in autoimmune sialoadenitis of MRL/lpr mice.
Mustafa W; Sharafeldin A; Diab A; Huang YM; Bing H; Zhu J; Link H; Frithiof L; Klinge B
Scand J Immunol; 1998 Dec; 48(6):623-8. PubMed ID: 9874496
[TBL] [Abstract][Full Text] [Related]
6. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
7. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Zou LP; Pelidou SH; Abbas N; Deretzi G; Mix E; Schaltzbeerg M; Winblad B; Zhu J
J Neuroimmunol; 1999 Aug; 98(2):168-75. PubMed ID: 10430050
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
Distler O; Pap T; Kowal-Bielecka O; Meyringer R; Guiducci S; Landthaler M; Schölmerich J; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Müller-Ladner U
Arthritis Rheum; 2001 Nov; 44(11):2665-78. PubMed ID: 11710722
[TBL] [Abstract][Full Text] [Related]
10. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
Scala E; Pallotta S; Frezzolini A; Abeni D; Barbieri C; Sampogna F; De Pità O; Puddu P; Paganelli R; Russo G
Clin Exp Immunol; 2004 Dec; 138(3):540-6. PubMed ID: 15544634
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.
Fisher NC; Neil DA; Williams A; Adams DH
Gut; 1999 Sep; 45(3):416-20. PubMed ID: 10446112
[TBL] [Abstract][Full Text] [Related]
12. Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes.
Møller AS; Øvstebø R; Westvik AB; Joø GB; Haug KB; Kierulf P
J Endotoxin Res; 2003; 9(6):349-60. PubMed ID: 14733721
[TBL] [Abstract][Full Text] [Related]
13. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.
Galindo M; Santiago B; Rivero M; Rullas J; Alcami J; Pablos JL
Arthritis Rheum; 2001 Jun; 44(6):1382-6. PubMed ID: 11407698
[TBL] [Abstract][Full Text] [Related]
14. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the temporal expression of chemokines and chemokine receptors during experimental granulomatous inflammation: role and expression of MIP-1alpha and MCP-1.
Carollo M; Hogaboam CM; Kunkel SL; Delaney S; Christie MI; Perretti M
Br J Pharmacol; 2001 Nov; 134(6):1166-79. PubMed ID: 11704636
[TBL] [Abstract][Full Text] [Related]
16. Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis.
Hashimoto S; Nakayama T; Gon Y; Hata N; Koura T; Maruoka S; Matsumoto K; Hayashi S; Abe Y; Horie T
Clin Exp Immunol; 1998 Mar; 111(3):604-10. PubMed ID: 9528906
[TBL] [Abstract][Full Text] [Related]
17. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
Adamus G; Manczak M; Machnicki M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
[TBL] [Abstract][Full Text] [Related]
18. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation.
Karpus WJ; Kennedy KJ
J Leukoc Biol; 1997 Nov; 62(5):681-7. PubMed ID: 9365124
[TBL] [Abstract][Full Text] [Related]
19. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
[TBL] [Abstract][Full Text] [Related]
20. SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice.
Kimura M; Kawahito Y; Hamaguchi M; Nakamura T; Okamoto M; Matsumoto Y; Endo H; Yamamoto A; Ishino H; Wada M; Omoto A; Tsubouchi Y; Kohno M; Yoshikawa T
Biomed Pharmacother; 2007 May; 61(4):222-8. PubMed ID: 17147981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
